Comparing Biologic Cost Per Treated Patient Across Indications Among Adult US Managed Care Patients: A Retrospective Cohort Study

BACKGROUND: The relative cost of biologics in the treatment of autoimmune disorders, including rheumatoid arthritis, psoriatic arthritis, psoriasis, and ankylosing spondylitis, is a key consideration for managed care payers. OBJECTIVES: Our objective was to estimate biologic costs and treatment patt...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Tao, Shah, Neel, Deshpande, Gaurav, Tang, Derek H., Eisenberg, Debra F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127933/
https://www.ncbi.nlm.nih.gov/pubmed/27757919
http://dx.doi.org/10.1007/s40801-016-0093-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127933/
https://www.ncbi.nlm.nih.gov/pubmed/27757919
http://dx.doi.org/10.1007/s40801-016-0093-2

Ejemplares similares